Bivalirudin and provisional glyco-protein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/ IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial - Lincoff, AM; REPLACE-2 Investigators. (J Am Med Assoc, 2003)